Mizuho Securities’s MEDIROM Healthcare Technologies MRM Stock Holding History

Mizuho Securities’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-68,500	Closed	-$664K	–	208
2021 Q2	$664K	Hold	68,500	–	–	0.13%	30
2021 Q1	$782K	Hold	68,500	–	–	0.16%	13
2020 Q4	$986K	Buy	+68,500	New	+$1.01M	0.19%	14

Other funds holding MRM

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mizuho Securities's MRM Position: Q3 2021 in Review

Mizuho Securities sold out of MEDIROM Healthcare Technologies (MRM) in Q3 2021, closing a stake of 68,500 shares — an estimated $664K sold.

Mizuho Securities first reported a position in MRM in Q4 2020 and held it in 3 quarters. The position peaked at $986K in Q4 2020. 5 funds tracked by Wall St. Rank hold MRM as of Q3 2021.

Mizuho Securities reported no remaining MEDIROM Healthcare Technologies position as of Q3 2021 after selling out during the quarter.
Mizuho Securities sold 68,500 MEDIROM Healthcare Technologies shares in Q3 2021, an estimated $664K.
Mizuho Securities first reported a position in MEDIROM Healthcare Technologies in Q4 2020 and held it in 3 quarters.
Mizuho Securities's MEDIROM Healthcare Technologies position peaked at $986K in Q4 2020.
5 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q3 2021.

Based on Mizuho Securities's 13F filing for Q3 2021, filed 5 Nov 2021.